BeOne Medicines' BTK degrader gains EMA PRIME designation
The EMA's Committee for Medicinal Products for Human Use (CHMP) granted the designation based on the therapy's novel mechanism and data showing its anti-tumour activity in B-cell malignancies.
BeOne Medicines chief regulatory affairs officer and senior vice-president Julie Lepin stated: 'This is the company's first PRIME designation, marking a milestone for BeOne and providing early and enhanced interaction with the EMA as we advance BGB-16673.
'PRIME allows us to align early with the EMA on key evidence requirements and potentially accelerate our path to marketing authorisation of BGB-16673 for patients with relapsed or refractory Waldenstrom's macroglobulinemia.'
BGB-16673 is an oral therapy from the company's chimeric degradation activation compound platform.
It is developed to facilitate the degradation of BTK's mutant and wild-type forms, including those that lead to resistance to BTK inhibitors in individuals with progressive conditions.
The therapy is the most advanced BTK protein degrader in clinical development, with a global clinical development programme.
The PRIME initiative aims to offer early support to medicine developers, enhancing development plans and expediting assessments to deliver therapies to individuals with unmet medical requirements.
CHMP also gave a positive opinion on the European Union orphan drug designation application for the therapy in this indication, with the final decision expected shortly.
BGB-16673 has also secured fast-track designation from the US Food and Drug Administration to treat adults with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, and with relapsed or refractory mantle cell lymphoma.
In July 2025, BeOne Medicines secured approval from the European Commission for Tevimbra (tislelizumab) to be used in combination with gemcitabine and cisplatin for adults with metastatic or recurrent nasopharyngeal carcinoma for whom curative surgery or radiotherapy is not an option.
"BeOne Medicines' BTK degrader gains EMA PRIME designation " was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Dollar weakens as rate cut odds rise, tariff uncertainties linger
By Ankur Banerjee and Gregor Stuart Hunter SINGAPORE (Reuters) -The U.S. dollar wavered on Tuesday as the rising odds of Federal Reserve rate cuts weighed on sentiment, while investors assessed the broader economic impact of U.S. tariffs unleashed last week. The dollar remained under pressure following Friday's U.S. jobs report that showed cracks in the labour market, prompting traders to swiftly price in rate cuts next month. U.S. President Donald Trump's firing of a top statistics official and the resignation of Federal Reserve Governor Adriana Kugler also exacerbated market unease, leading to a sharp dive in the dollar on Friday. The U.S. currency found its footing on Monday but was weaker in early trading on Tuesday. The euro last bought $1.1579 while sterling stood at $1.3298. The dollar index, which measures the U.S. currency against six other units, was at 98.688 after touching a one-week low earlier in the session. Traders are now pricing in a 94.4% chance of the Fed cutting rates in its next meeting in September, compared to 63% a week earlier, CME FedWatch tool showed. Goldman Sachs expects the Fed to deliver three consecutive 25 basis point cuts starting in September, with a 50 basis point move possible if the unemployment rate climbs further in the next report. San Francisco Federal Reserve Bank President Mary Daly said on Monday that given mounting evidence that the U.S. jobs market is softening and no signs of persistent tariff-driven inflation, the time is nearing for rate cuts. "I was willing to wait another cycle, but I can't wait forever," Daly said. Meanwhile, the focus remains on tariff uncertainties after the latest duties imposed on scores of countries last week by Trump, stoked worries about the health of the global economy. The Japanese yen firmed slightly to 146.95 per dollar after minutes of its June policy meeting showed a few Bank of Japan board members said the central bank would consider resuming interest rate increases if trade frictions de-escalate. The Swiss franc was steady at 0.8081 per dollar after dropping 0.5% in the previous session as Switzerland geared up to make a "more attractive offer" in trade talks with Washington to avert a 39% U.S. import tariff on Swiss goods that threatens to hammer its export-driven economy. The long-term impact of the tariffs though remains uncertain, with traders bracing for volatility. "This is going to be like the pandemic, we all expect to see the transitory impact on supply chains to happen very quickly," said Rodrigo Catril, currency strategist at National Australia Bank in Sydney. "It'll probably take six months to a year to see exactly where we land and who's going to be winners and losers from all this." In other currencies, the Australian dollar was 0.11% higher at $0.64736, while the New Zealand dollar rose 0.11% to $0.5914. "We're still of a view that the big dollar is heading down," Catril said, referring to the U.S. dollar. "While global growth means pro-growth currencies like Asian currencies and the AUD should struggle, we've other structural dynamics in the USD, where policies are dollar-negative."
CNBC
40 minutes ago
- CNBC
India calls out EU and U.S.' trade with Russia after Trump threatens steeper tariffs on New Delhi
India said it was is being "targeted" by the U.S. and the European Union over its imports of Russian oil after U.S. President Donald Trump in an overnight social media post threatened New Delhi with much steeper tariffs. India began importing oil from Russia only after traditional supplies were diverted to Europe following the outbreak of the Russia-Ukraine war in 2022, the country's foreign ministry said in a statement late Monday. The ministry called out the EU and the U.S. saying, "it is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion [for them]." The EU's bilateral trade with Russia stood at 67.5 billion euros ($78.1 billion) in 2024, while its services trade in 2023 was at 17.2 billion euros, according to European Commission data. Citing that data, India said the bloc's trade was "significantly more" than India's total trade with Russia. Data from the Indian embassy in Moscow showed bilateral trade between New Delhi and Moscow reached a record $68.7 billion for the year ended March 2025, nearly 5.8 times higher than the pre-pandemic trade of $10.1 billion. The EU, meanwhile, was Russia's third-biggest trade partner in 2024, accounting for 38.4% of the bloc's total trade with the country, sliding from being Moscow's top partner in 2020. EU's goods trade with Russia dropped to 67.5 billion euros in 2024 from 257.5 billion euros in 2021. India's response comes after Trump threatened on Monday that he would be "substantially raising" the tariffs on India, although he did not specify the level of the higher tariffs. The U.S. president had threatened a 25% duty on Indian exports, as well as an unspecified "penalty" last week. He also accused India of buying discounted Russian oil and "selling it on the Open Market for big profits." Russia became the leading oil supplier to India since the war in Ukraine began, increasing imports from just under 100,000 barrels per day before the invasion, or a 2.5% of its total imports, to more than 1.8 million barrels per day in 2023, or 39%, according to the U.S. Energy Information Administration's report earlier this year. "The United States at that time actively encouraged such imports by India for strengthening global energy markets stability," the country said in its statement. According to the International Energy Agency, 70% of Russian crude was exported to India in 2024. India said oil imports were meant to ensure predictable and affordable energy costs to the Indian consumer. India has in the past defended its oil purchases from Russia, with Hardeep Singh Puri, the country's energy minister, saying in an interview last month with CNBC that New Delhi helped stabilize global energy prices and was encouraged by the U.S. to do so. "If people or countries had stopped buying at that stage, the price of oil would have gone up to 130 dollars a barrel. That was a situation in which we were advised, including by our friends in the United States, to please buy Russian oil, but within the price cap," Puri said. India also took aim at the U.S, saying the country continues to import uranium hexafluoride for its nuclear industry, palladium for the electric-vehicle industry, as well as fertilizers and chemicals. U.S. bilateral trade with Russia in 2024 stood at $5.2 billion, compared with nearly $36 billion in 2021, government data showed. The U.S. has not imposed any "reciprocal tariffs" on Russia. "In this background, the targeting of India is unjustified and unreasonable. Like any major economy, India will take all necessary measures to safeguard its national interests and economic security," New Delhi said.
Yahoo
an hour ago
- Yahoo
Dollar weakens as rate cut odds rise, tariff uncertainties linger
By Ankur Banerjee and Gregor Stuart Hunter SINGAPORE (Reuters) -The U.S. dollar wavered on Tuesday as the rising odds of Federal Reserve rate cuts weighed on sentiment, while investors assessed the broader economic impact of U.S. tariffs unleashed last week. The dollar remained under pressure following Friday's U.S. jobs report that showed cracks in the labour market, prompting traders to swiftly price in rate cuts next month. U.S. President Donald Trump's firing of a top statistics official and the resignation of Federal Reserve Governor Adriana Kugler also exacerbated market unease, leading to a sharp dive in the dollar on Friday. The U.S. currency found its footing on Monday but was weaker in early trading on Tuesday. The euro last bought $1.1579 while sterling stood at $1.3298. The dollar index, which measures the U.S. currency against six other units, was at 98.688 after touching a one-week low earlier in the session. Traders are now pricing in a 94.4% chance of the Fed cutting rates in its next meeting in September, compared to 63% a week earlier, CME FedWatch tool showed. Goldman Sachs expects the Fed to deliver three consecutive 25 basis point cuts starting in September, with a 50 basis point move possible if the unemployment rate climbs further in the next report. San Francisco Federal Reserve Bank President Mary Daly said on Monday that given mounting evidence that the U.S. jobs market is softening and no signs of persistent tariff-driven inflation, the time is nearing for rate cuts. "I was willing to wait another cycle, but I can't wait forever," Daly said. Meanwhile, the focus remains on tariff uncertainties after the latest duties imposed on scores of countries last week by Trump, stoked worries about the health of the global economy. The Japanese yen firmed slightly to 146.95 per dollar after minutes of its June policy meeting showed a few Bank of Japan board members said the central bank would consider resuming interest rate increases if trade frictions de-escalate. The Swiss franc was steady at 0.8081 per dollar after dropping 0.5% in the previous session as Switzerland geared up to make a "more attractive offer" in trade talks with Washington to avert a 39% U.S. import tariff on Swiss goods that threatens to hammer its export-driven economy. The long-term impact of the tariffs though remains uncertain, with traders bracing for volatility. "This is going to be like the pandemic, we all expect to see the transitory impact on supply chains to happen very quickly," said Rodrigo Catril, currency strategist at National Australia Bank in Sydney. "It'll probably take six months to a year to see exactly where we land and who's going to be winners and losers from all this." In other currencies, the Australian dollar was 0.11% higher at $0.64736, while the New Zealand dollar rose 0.11% to $0.5914. "We're still of a view that the big dollar is heading down," Catril said, referring to the U.S. dollar. "While global growth means pro-growth currencies like Asian currencies and the AUD should struggle, we've other structural dynamics in the USD, where policies are dollar-negative." Sign in to access your portfolio
